Companies · Other Health Care

Previser Corp

CONCORD · Other Health Care

Diligence memoA one-page analyst read on Previser Corp — recommendation, valuation, rhythm, risks.
$8.8M
Total raised · real
2
Rounds
0.5×
Latest step-up
Top 27%
Sector rank · raised
Series A
Latest stage · inferred · Mon Jun 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Previser Corp looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.39× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
  • Within the normal band (139% of peer median) for its niche.
Dormant
  • Last raise 10.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Previser Corp is one of 5376 Other Health Care companies tracked from CONCORD. By capital raised it ranks in the upper tier (ahead of 74% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2016-06-06
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2012-12-20 Raised $500K (real) Modeled valuation $15M (est)Pre-Seed2012Pre-Seed · 2012-12-20 Raised $350K (real) Modeled valuation $11M (est)Pre-Seed2012Series A · 2016-06-06 Raised $5.0M (real) Modeled valuation $101M (est)Series A2016Series A · 2016-06-06 Raised $8.3M (real) Modeled valuation $168M (est)Series A2016Seed · 2016-06-06 Raised $3.0M (real) Modeled valuation $74M (est)Seed2016Seed · 2016-06-06 Raised $2.0M (real) Modeled valuation $50M (est)Seed2016Pre-Seed · 2016-06-06 Raised $1.0M (real) Modeled valuation $31M (est)Pre-Seed2016+$350K+$5.0M+$8.3M+$3.0M+$2.0M+$1.0MCumulative $20M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$500K · 2012
Pre-Seed extension$350K · 2012
Series A$5.0M · 2016no Seed on file
Series A extension$8.3M · 2016
Bridge · Series A-stage$3.0M · 2016smaller follow-on
Bridge · Series A-stage$2.0M · 2016smaller follow-on
Bridge · Series A-stage$1.0M · 2016smaller follow-on

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$168.5M
Base estimate est.
$10.7M
Conservative case
$916.2M
Upside case
$38.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $15.4M · 2012-12-202012Pre-Seed · modeled $10.8M · 2012-12-20Series A · modeled $100.9M · 2016-06-06Series A · modeled $168.5M · 2016-06-06Seed · modeled $74.4M · 2016-06-06Seed · modeled $49.6M · 2016-06-06Pre-Seed · modeled $30.8M · 2016-06-062016
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
10.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$2.6M/yr
Capital velocity
13.5 yr
On record since
2012
First round
7
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.6× above median
This company$8.8M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$1.0M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 7.6× above median
This company$168.5M
Sector median$22.1M

Raised more than 74% of sector peers (real $). Modeled value above 86% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #45 of 157.

This companyCohort peer
$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)HemoSonics, LLC · Series A Raised $24.9M · modeled $302.7M (est)Airxpanders Inc · Series A Raised $60.0M · modeled $300.5M (est)Mercator Medsystems Inc · Series A Raised $20.5M · modeled $289.2M (est)Simple Contacts Inc. · Series A Raised $24.1M · modeled $285.5M (est)AVG Holdings, Inc. · Series A Raised $14.0M · modeled $282.5M (est)Avia Holdings, Llc · Series A Raised $27.9M · modeled $272.7M (est)Traditions at Rivertown Park, LLC · Series A Raised $13.5M · modeled $272.4M (est)Access Integrated Healthcare, LLC · Series A Raised $13.2M · modeled $265.8M (est)Gauss Surgical, Inc. · Series A Raised $20.5M · modeled $254.2M (est)4WEB, Inc. · Series A Raised $12.5M · modeled $252.2M (est)Iantech, Inc. · Series A Raised $12.2M · modeled $246.7M (est)AbsoluteCARE, Inc. · Series A Raised $25.7M · modeled $242.6M (est)Previser Corp (this company) Raised $8.8M · modeled $168.5M (est)Previser Corp
CompanyStageRaised · realValue · estvs peer med.
HemoSonics, LLCSeries A$24.9M$302.7M2.50×
Airxpanders IncSeries A$60.0M$300.5M2.48×
Mercator Medsystems IncSeries A$20.5M$289.2M2.39×
Simple Contacts Inc.Series A$24.1M$285.5M2.36×
AVG Holdings, Inc.Series A$14.0M$282.5M2.33×
Avia Holdings, LlcSeries A$27.9M$272.7M2.25×
Traditions at Rivertown Park, LLCSeries A$13.5M$272.4M2.25×
Access Integrated Healthcare, LLCSeries A$13.2M$265.8M2.20×
Gauss Surgical, Inc.Series A$20.5M$254.2M2.10×
4WEB, Inc.Series A$12.5M$252.2M2.08×
Iantech, Inc.Series A$12.2M$246.7M2.04×
AbsoluteCARE, Inc.Series A$25.7M$242.6M2.00×
Previser Corp this companySeries A$8.8M$168.5M1.39×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$500K2012-12-20$2.8M$15.4M85%
Pre-Seed$350K2012-12-20$1.9M$10.8M85%
Series A$5.0M2016-06-06$22.7M$100.9M90%
Series A$8.3M2016-06-06$38.0M$168.5M90%
Seed$3.0M2016-06-06$15.0M$74.4M90%
Seed$2.0M2016-06-06$10.0M$49.6M85%
Pre-Seed$1.0M2016-06-06$5.6M$30.8M85%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$500K2012-12-20
    • First recorded raise — entered as Pre-Seed.
    • 7 investors on this round.
  2. Pre-Seed$350K2012-12-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
    • Switched to Rule 06 (was Rule 506(b)).
    • 4 investors on this round.
  3. Series A$5.0M2016-06-06
    • Raised again after 42 mo — slower than the ~14 mo sector norm.
    • Round 14.3× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 3 investors on this round.
  4. Series A$8.3M2016-06-06
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× larger than the prior — scaling up.
    • 3 investors on this round.
  5. Seed$3.0M2016-06-06
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.8× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  6. Seed$2.0M2016-06-06
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  7. Pre-Seed$1.0M2016-06-06
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2017 ~Q1
Modeled next raise · ~7mo cadence
$1.0M
Modeled next size est.range $1.0M$1.6M
0.5×
Last step-up
$2.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Frederick Eichmiller1 other2016-06
Jon Anderson1 other2012-12
Peter Hoover1 other2012-12
Carl Loeb2012-12
Erica Bodwell2016-06
Francis Boucher2016-06
Glossy Bernard2016-06
John Maples2016-06
Martin Page2012-12
Michael Bourbeau2016-06
Mikyn Sygitowicz2012-12
Roy Page2012-12
Shane Gildnes2012-12
Thomas Raffio2016-06
Registry & provenance

Previser Corp is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1395580
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Fresenius Vascular Care Pensacola, LLCOther Health CareSeries A$8.9M$178.7Msame sector · same stage
Docusys IncOther Health CareSeries A$8.8M$178.4Msame sector · same stage
Gramercy Extremity Orthopedics, LLCOther Health CareSeries A$8.8M$178.3Msame sector · same stage
Red Fox Holding CorpOther Health CareSeries A$8.9M$179.2Msame sector · same stage
NY Medicinal Research & Caring, LLCOther Health CareSeries A$8.8M$178.0Msame sector · same stage
Thrive ManagementCo, LLCOther Health CareSeries A$8.9M$116.1Msame sector · same stage
USRC Eastern Iowa, LLCOther Health CareSeries A$8.9M$179.5Msame sector · same stage
Tree Street HoldingsOther Health CareSeries A$8.8M$177.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Prevail Holdings, IncOther Health CarePre-Seed$15.4M90%
Preveta CorpOther Health CareSeries A$52.2M89%
Pregimmune CorpOther Health CarePre-Seed$1.5M87%
Prenuvo, Inc.Other Health CareSeries C$699.7M85%
Prescriber's Choice, Inc.Other Health CareSeed$31.8M85%
Predigen, Inc.Other Health CarePre-Seed$15.4M83%
Previvo Genetics, Inc.Other Health CareSeries A$201.8M83%
Wellprept, Inc.Other Health CarePre-Seed$5.0M83%
Frequently asked
How much funding has Previser Corp raised?
Previser Corp has raised approximately $8.8M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Previser Corp's estimated valuation?
Provath's modeled valuation for Previser Corp is approximately $168.5M (modeled range $10.7M–$916.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Previser Corp at?
Previser Corp's latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Jun 06.
What does Previser Corp do and where is it based?
Previser Corp operates in the Other Health Care sector, based in CONCORD.
Explore related

See where Previser Corp sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Previser Corp, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.